Clinical Trial Update: Cardiovascular Risk Reduction Program Aimed at African American Women (The HHER Lifestyle Program) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of the HHER Lifestyle Program, a cardiovascular risk reduction program for African American women, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Cardiovascular Diseases | Phase 3 | Status: COMPLETED